<

 
Data updated 2025-05-02 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date10769052.1 (espacenet)  (Federated)  (European Patent Register), 20101025
Patent/reg. no. and dateDK/EP 2493870, 20141217
Publication date20120905
Priority no. and dateEP 09306017, 20091027
EP pub. no. and date EP 2493870 20120905
Effective date
Applicant/ownerAstraZeneca AB,
151 85 Södertälje, SE
Applicant ref. no.Astra 103831-EP-EPT
InventorBARLAAM, Bernard, Christophe, AstraZeneca Pharma
Z.I La Pompelle
BP 1050
F-51689 Reims Cedex 2, FR,
DEGORCE, Sebastien, Louis, AstraZeneca Pharma
Z.I La Pompelle
BP 1050
F-51689 Reims Cedex 2, FR,
LAMBERT-VAN DER BREMPT, Christine, Marie, Paul, AstraZeneca Pharma
Z.I La Pompelle
BP 1050
F-51689 Reims Cedex 2, FR,
MORGENTIN, Remy, Robert, AstraZeneca Pharma
Z.I La Pompelle
BP 1050
F-51689 Reims Cedex 2, FR,
PLE, Patrick, AstraZeneca Pharma
Z.I La Pompelle
BP 1050
F-51689 Reims Cedex 2, FR
RepresentativeRWS Group, RWS Compass House Vanwall Business Park, Vanwall Road Maidenhead, Berkshire SL6 4UB, GB
Opponent
IPC ClassA61K 31/5377 (2006.01) , A61K 31/558 (2006.01) , C07D 311/22 (2006.01) 
TitleCHROMENONDERIVATER MED ANTITUMORAKTIVITET
Int. application no.GB2010051788
Int. publication no.WO2011051704
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact